These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4984503)

  • 61. [A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
    Ramarokoto H; Andrianasolo D; Rasolonavalona T; Ramaroson F; Razafitsiarovana I; Vincent V; Ratsimba L; Rasolofo Razanamparany V
    Arch Inst Pasteur Madagascar; 2003; 69(1-2):37-40. PubMed ID: 15678814
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
    Singla R; Gupta S; Gupta R; Arora VK
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):559-63. PubMed ID: 11409584
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Causes of persistent acid-fast positive smears in pulmonary tuberculosis.
    Franco-Paredes C; Ray S
    Am J Med; 2012 Dec; 125(12):e3-4. PubMed ID: 22795813
    [No Abstract]   [Full Text] [Related]  

  • 64. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
    Zhangireev AA; Ismailov ShSh; Berikova EM
    Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [L-forms of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis].
    Karachunskiĭ MA; Dorozhkova IR; Kaminskaia AA; Abdullaeva ET
    Probl Tuberk; 1983 Jul; (7):38-43. PubMed ID: 6415651
    [No Abstract]   [Full Text] [Related]  

  • 66. Rifampicin in the treatment of resistant pulmonary tuberculosis.
    Wäre M; Lorenzen J
    Scand J Respir Dis Suppl; 1970; 72():113-9. PubMed ID: 4990617
    [No Abstract]   [Full Text] [Related]  

  • 67. [Evaluation of early results of treatment of pulmonary tuberculosis in Mycobacterium-positive patients. Comparison of the results of 3- and 4-drug treatment].
    Martyniak K; Wyczółkowski M; Bochiński T
    Pneumonol Pol; 1985 Apr; 53(4):195-201. PubMed ID: 3931056
    [No Abstract]   [Full Text] [Related]  

  • 68. [Comparative study of two regimens, KM-TH-CS and KM-TH-EB, in retreatment cases of pulmonary tuberculosis].
    Aoyagi T; Fukuhara Y; Hondo G; Matsumiya T; Murata A
    Kekkaku; 1970 Jan; 45(1):27-36. PubMed ID: 5416951
    [No Abstract]   [Full Text] [Related]  

  • 69. Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
    Virchow C; Flemming J
    Acta Tuberc Pneumol Belg; 1969; 60(3):466-70. PubMed ID: 5371671
    [No Abstract]   [Full Text] [Related]  

  • 70. [Renal function in patients with pulmonary tuberculosis treated with ethambutol in combination with other antitubercular drugs].
    Kvasnitskiĭ BI
    Probl Tuberk; 1978 Sep; (9):45-8. PubMed ID: 704597
    [No Abstract]   [Full Text] [Related]  

  • 71. Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections.
    Vall-Spinosa A; Lester W; Moulding T; Davidson PT; McClatchy JK
    N Engl J Med; 1970 Sep; 283(12):616-21. PubMed ID: 4988918
    [No Abstract]   [Full Text] [Related]  

  • 72. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P
    Fortschr Med; 1983 Jun; 101(23):1075-80, 1090. PubMed ID: 6411560
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ethambutol treatment of tuberculosis in a controlled trial.
    Segarra FO; Lorian V; Sherman DS
    Scand J Respir Dis; 1968; 49(3):202-6. PubMed ID: 4980226
    [No Abstract]   [Full Text] [Related]  

  • 74. [Determination of adequate drug combinations in the treatment of cavernous tuberculosis].
    Seri I
    Prax Pneumol; 1971 Apr; 25(4):211-9. PubMed ID: 4995326
    [No Abstract]   [Full Text] [Related]  

  • 75. Capreomycin and ethambutol in pulmonary tuberculosis. A preliminary report.
    Repo UK; Hellström PE
    Scand J Respir Dis Suppl; 1970; 72():72-5. PubMed ID: 5273730
    [No Abstract]   [Full Text] [Related]  

  • 76. Capreomycin-experiences in patient acceptance and toxicity.
    Browning RH; Donnerberg RL
    Ann N Y Acad Sci; 1966 Apr; 135(2):1057-64. PubMed ID: 5220234
    [No Abstract]   [Full Text] [Related]  

  • 77. Ethambutol-isoniazid versus PAS-isoniazid in original treatment of pulmonary tuberculosis.
    Bobrowitz ID; Robins DE
    Am Rev Respir Dis; 1967 Sep; 96(3):428-38. PubMed ID: 6039097
    [No Abstract]   [Full Text] [Related]  

  • 78. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV; Pashkov IuN; Pospelov VV
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract]   [Full Text] [Related]  

  • 79. [Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients].
    Kameda K; Kudo S; Iwai K; Ushikubo K
    Kekkaku; 1970 Sep; 45(9):283-7. PubMed ID: 4989932
    [No Abstract]   [Full Text] [Related]  

  • 80. Permeability of tuberculous cavities to antituberculosis drugs.
    Tsukamura M
    Tubercle; 1972 Mar; 53(1):47-52. PubMed ID: 4114097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.